Report

  • Home |
  • Reports |
  • Global Traumatic Brain Injury Therapeutics Market by Product Type (Acetylcholine....
src

Global Traumatic Brain Injury Therapeutics Market by Product Type (Acetylcholinesterase Inhibitors, Erythropoietin, Growth Hormone, Stem Cells and Other) and by End-Users/Application (Focal TBI, Open TBI, Closed TBI and Diffuse TBI) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2014 - 2026

Press Release
Global traumatic brain injury therapeutics market report offers in-depth insights, revenue details, and other vital information regarding the global traumatic brain injury therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2026. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Traumatic brain injury therapeutics market research report comprises insightful and detailed information regarding the various key players involved in the global traumatic brain injury therapeutics market along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

The report on traumatic brain injury therapeutics market provides a decisive view of the global traumatic brain injury therapeutics market by segmenting it in terms of product type and applications. These segments have been analyzed based on present and future trends. Regional segmentation includes the current and forecasted demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report also covers demand for individual end-user segments in all the regions.

Traumatic brain injury therapeutics market research report also includes manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Highlights of the report:
  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
Market Segmentation:

Segmentation by Type:
  • Acetylcholinesterase Inhibitors
  • Erythropoietin
  • Growth Hormone
  • Stem Cells
  • Others
Segmentation by Application:
  • Focal TBI
  • Open TBI
  • Closed TBI
  • Diffuse TBI
Market, By Regions:
  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, UK, France, Italy, and Russia, etc.)
  • Asia-Pacific (China, Japan, ASEAN, India, and Korea)
  • The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
  • South America (Brazil, Chile, Peru, and Argentina)
Scope of Traumatic Brain Injury Therapeutics Market Report:

Report provides factors that are contributing to and influencing the expansion of the global traumatic brain injury therapeutics market. It projects the market assessment for the predicted time. It also provides various drivers that are boosting the market. Moreover, the major product type and segments are covered with their complete analysis in the report. Applications with different segment are overviewed in the report. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
 
Table of Content

Chapter 1    Traumatic Brain Injury Therapeutics Market Overview    21
1.1    Product Overview and Scope of Traumatic Brain Injury Therapeutics    21
1.2    Traumatic Brain Injury Therapeutics Segment by Types (Product Category)    23
    1.2.1    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Comparison by Types (2014-2019)    23
    1.2.2    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Types in 2018    24
    1.2.3    Acetylcholinesterase Inhibitors    25
    1.2.4    Erythropoietin    26
    1.2.5    Growth Hormone    27
    1.2.6    Stem Cells    28
    1.2.7    Other    29
1.3    Global Traumatic Brain Injury Therapeutics Segment by Applications    30
    1.3.1    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Comparison by Applications (2014-2026)    30
    1.3.2    Focal TBI    32
    1.3.3    Open TBI    33
    1.3.4    Closed TBI    34
    1.3.5    Diffuse TBI    35
1.4    Global Traumatic Brain Injury Therapeutics Market by Regions (2014-2026)    36
    1.4.1    Global Traumatic Brain Injury Therapeutics Market Size and Growth Rate (%) Comparison by Regions (2014-2026)    36
    1.4.2    North America Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    38
    1.4.3    Europe Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    39
    1.4.4    China Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    40
    1.4.5    Japan Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    41
    1.4.6    Southeast Asia Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    42
    1.4.7    India Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    43
    1.4.8    South America Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    44
    1.4.9    Middle East & Africa Traumatic Brain Injury Therapeutics Status and Prospect (2014-2026)    45
1.5    Global Traumatic Brain Injury Therapeutics Market Size (2014-2026)    46
    1.5.1    Global Traumatic Brain Injury Therapeutics Revenue Status and Outlook (2014-2026)    46
    
Chapter 2    Global Traumatic Brain Injury Therapeutics Market Competition by Manufacturers    47
2.1    Global Traumatic Brain Injury Therapeutics Revenue and Share by Manufacturers (2013-2017)    47

Chapter 3    Company (Top Players) Profiles and Key Data    50
3.1    Banyan Biomarkers, Inc.    50
    3.1.1    Banyan Biomarkers, Inc. Company Basic Information, Manufacturing Base, Sales Area and its Competitors    50
    3.1.2    Business Segment/ Overview    51
    3.1.3    Traumatic Brain Injury Therapeutics Specification    52
    3.1.4    Key Developments    54
    3.1.5    Business Strategy    55
3.2    ElMindA Ltd.    56
    3.2.1    ElMindA Ltd. Company Basic Information, Manufacturing Base, Sales Area and its Competitors    56
    3.2.2    Business Segment/ Overview    57
    3.2.3    Business Strategy    60
3.3    Grace laboratories, LLC.    61
    3.3.1    Grace laboratories, LLC. Company Basic Information, Manufacturing Base, Sales Area and its Competitors    61
    3.3.2    Business Segment/ Overview    62
    3.3.3    Business Strategy    65
3.4    NeuroVive Pharmaceutical AB    66
    3.4.1    NeuroVive Pharmaceutical AB Company Basic Information, Manufacturing Base, Sales Area and its Competitors    66
    3.4.2    Business Segment/ Overview    67
    3.4.3    Traumatic Brain Injury Therapeutics Specification    68
    3.4.4    Business Strategy    70
3.5    BHR Pharma, LLC    71
    3.5.1    BHR Pharma, LLC Company Basic Information, Manufacturing Base, Sales Area and its Competitors    71
    3.5.2    Business Segment/ Overview    72
    3.5.3    Traumatic Brain Injury Therapeutics Specification    73
    3.5.4    Business Strategy    74
3.6    Cerora, Inc.    75
    3.6.1    Cerora, Inc. Company Basic Information, Manufacturing Base, Sales Area and its Competitors    75
    3.6.2    Business Segment/ Overview    76
    3.6.3    Business Strategy    77
3.7    Neuro Assessment Systems, Inc.    78
    3.7.1    Neuro Assessment Systems, Inc. Company Basic Information, Manufacturing Base, Sales Area and its Competitors    78
    3.7.2    Business Segment/ Overview    79
    3.7.3    Traumatic Brain Injury Therapeutics Specification    80
    3.7.4    Business Strategy    81
3.8    Silver Creek Pharmaceuticals, Inc.    82
    3.8.1    Silver Creek Pharmaceuticals, Inc. Company Basic Information, Manufacturing Base, Sales Area and its Competitors    82
    3.8.2    Business Segment/ Overview    83
    3.8.3    Business Strategy    84
    
Chapter 4    Global Traumatic Brain Injury Therapeutics Revenue by Regions (2014-2019)    85
4.1    Global Traumatic Brain Injury Therapeutics Revenue and Market Share (%) by Regions (2014-2019)    85

Chapter 5    Global Traumatic Brain Injury Therapeutics Revenue by Types    89
5.1    Global Traumatic Brain Injury Therapeutics Revenue and Market Share (%) by Types (2014-2019)    89

Chapter 6    Global Traumatic Brain Injury Therapeutics Market Analysis by Applications    92
6.1    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) and Market Share (%) by Applications (2014-2019)    92
6.2    Global Traumatic Brain Injury Therapeutics Revenue Growth Rate by Applications (2014-2019)    96

Chapter 7    North America Traumatic Brain Injury Therapeutics Market Development Status and Outlook    97
7.1    North America Traumatic Brain Injury Therapeutics Market Size (2014-2019)    97
    7.1.1    North America Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    98
7.2    North America Traumatic Brain Injury Therapeutics Market Size (2014-2019)    99
    7.2.1    North America Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    100
    
Chapter 8    Europe Traumatic Brain Injury Therapeutics Market Development Status and Outlook    101
8.1    Europe Traumatic Brain Injury Therapeutics Market Size (2014-2019)    101
    8.1.1    Europe Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    102
8.2    Europe Traumatic Brain Injury Therapeutics Market Size (2014-2019)    103
    8.2.1    Europe Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    104
    
Chapter 9    China Traumatic Brain Injury Therapeutics Market Development Status and Outlook    105
9.1    China Traumatic Brain Injury Therapeutics Market Size (2014-2019)    105
    9.1.1    China Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    106
9.2    China Traumatic Brain Injury Therapeutics Market Size (2014-2019)    107
    9.2.1    China Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    108
    
Chapter 10    Japan Traumatic Brain Injury Therapeutics Market Development Status and Outlook    109
10.1    Japan Traumatic Brain Injury Therapeutics Market Size (2014-2019)    109
    10.1.1    Japan Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    110
10.2    Japan Traumatic Brain Injury Therapeutics Market Size (2014-2019)    112
    10.2.1    Japan Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    113
    10.2.2    Japan Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    114
    
Chapter 11    Southeast Asia Traumatic Brain Injury Therapeutics Market Development Status and Outlook    115
11.1    Southeast Asia Traumatic Brain Injury Therapeutics Market Size (2014-2019)    115
    11.1.1    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    116
11.2    Southeast Asia Traumatic Brain Injury Therapeutics Market Size (2014-2019)    118
    11.2.1    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    119
    
Chapter 12    India Traumatic Brain Injury Therapeutics Market Development Status and Outlook    120
12.1    India Traumatic Brain Injury Therapeutics Market Size (2014-2019)    120
    12.1.1    India Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    121
12.2    India Traumatic Brain Injury Therapeutics Market Size (2014-2019)    123
    12.2.1    India Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    124
    
Chapter 13    South America Traumatic Brain Injury Therapeutics Market Development Status and Outlook    125
13.1    South America Traumatic Brain Injury Therapeutics Market Size (2014-2019)    125
    13.1.1    South America Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    126
13.2    South America Traumatic Brain Injury Therapeutics Market Size (2014-2019)    127
    13.2.1    South America Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    128
    
Chapter 14    Middle East & Africa Traumatic Brain Injury Therapeutics Market Development Status and Outlook    129
14.1    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size (2014-2019)    129
    14.1.1    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    130
14.2    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size (2014-2019)    131
    14.2.1    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    132
    
Chapter 15    Traumatic Brain Injury Therapeutics Manufacturing Cost Analysis    134
15.1    Proportion of Manufacturing Cost Structure    134
    15.1.1    Raw Materials    134
    15.1.2    Labor Cost    135
    15.1.3    USA Labor Cost Analysis    135
    15.1.4    EU Labor Costs Analysis    137
    15.1.5    China Labor Costs Analysis    138
    15.1.6    Manufacturing Expenses    140
    
Chapter 16    Marketing Strategy Analysis, Distributors/Traders    141
16.1    Marketing Channel    141
    16.1.1    Direct Marketing    142
    16.1.2    Indirect Marketing    142
    16.1.3    Marketing Channel Development Trend    143
16.2    Market Positioning    143
    16.2.1    Pricing Strategy    144
    
Chapter 17    Global Traumatic Brain Injury Therapeutics Market Forecast (2019-2026)    145
17.1    Global Traumatic Brain Injury Therapeutics Revenue Forecast (2019-2026)    145
    17.1.1    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    145
17.2    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast by Regions (2019-2026)    146
    17.2.1    North America Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast (2019-2026)    148
    17.2.2    Europe Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast (2019-2026)    149
    17.2.3    China Traumatic Brain Injury Therapeutics and Revenue (USD Million) Forecast (2019-2026)    150
    17.2.4    Japan Traumatic Brain Injury Therapeutics and Revenue (USD Million) Forecast (2019-2026)    151
    17.2.5    Southeast Asia Traumatic Brain Injury Therapeutics and Revenue (USD Million) Forecast (2019-2026)    152
    17.2.6    India Traumatic Brain Injury Therapeutics and Revenue (USD Million) Forecast (2019-2026)    153
    17.2.7    South America Traumatic Brain Injury Therapeutics and Revenue (USD Million) Forecast (2019-2026)    154
    17.2.8    Middle East & Africa Traumatic Brain Injury Therapeutics and Revenue (USD Million) Forecast (2019-2026)    155
17.3    Global Traumatic Brain Injury Therapeutics Revenue Forecast by Type (2019-2026)    156
17.4    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast by Application (2019-2026)    158

Chapter 18    North America Traumatic Brain Injury Therapeutics Market Development Status and Outlook    160
18.1    North America Traumatic Brain Injury Therapeutics Market Size (2019-2026)    160
    18.1.1    North America Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    161
18.2    North America Traumatic Brain Injury Therapeutics Market Size (2019-2026)    162
    18.2.1    North America Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    163
    
Chapter 19    Europe Traumatic Brain Injury Therapeutics Market Development Status and Outlook    164
19.1    Europe Traumatic Brain Injury Therapeutics Market Size (2019-2026)    164
    19.1.1    Europe Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    165
19.2    Europe Traumatic Brain Injury Therapeutics Market Size (2019-2026)    166
    19.2.1    Europe Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    167
    
Chapter 20    China Traumatic Brain Injury Therapeutics Market Development Status and Outlook    168
20.1    China Traumatic Brain Injury Therapeutics Market Size (2019-2026)    168
    20.1.1    China Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    169
20.2    China Traumatic Brain Injury Therapeutics Market Size (2019-2026)    170
    20.2.1    China Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    171
    
Chapter 21    Japan Traumatic Brain Injury Therapeutics Market Development Status and Outlook    172
21.1    Japan Traumatic Brain Injury Therapeutics Market Size (2019-2026)    172
    21.1.1    Japan Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    173
21.2    Japan Traumatic Brain Injury Therapeutics Market Size (2019-2026)    174
    21.2.1    Japan Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    175
    
Chapter 22    Southeast Asia Traumatic Brain Injury Therapeutics Market Development Status and Outlook    176
22.1    Southeast Asia Traumatic Brain Injury Therapeutics Market Size (2019-2026)    176
    22.1.1    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    177
22.2    Southeast Asia Traumatic Brain Injury Therapeutics Market Size (2019-2026)    178
    22.2.1    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    179
    
Chapter 23    India Traumatic Brain Injury Therapeutics Market Development Status and Outlook    180
23.1    India Traumatic Brain Injury Therapeutics Market Size (2019-2026)    180
    23.1.1    India Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    181
23.2    India Traumatic Brain Injury Therapeutics Market Size (2019-2026)    182
    23.2.1    India Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    183
    
Chapter 24    South America Traumatic Brain Injury Therapeutics Market Development Status and Outlook    184
24.1    South America Traumatic Brain Injury Therapeutics Market Size (2019-2026)    184
    24.1.1    South America Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    185
24.2    South America Traumatic Brain Injury Therapeutics Market Size (2019-2026)    186
    24.2.1    South America Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    187
    
Chapter 25    Middle East & Africa Traumatic Brain Injury Therapeutics Market Development Status and Outlook    188
25.1    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size (2019-2026)    188
    25.1.1    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    189
25.2    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size (2019-2026)    190
    25.2.1    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    191
    
Chapter 26    Research Findings and Conclusion    192

List of Figures 

FIG. 1    Product Picture of Traumatic Brain Injury Therapeutics    22
FIG. 2    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Types in 2018    24
FIG. 3    Global Acetylcholinesterase Inhibitors Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026)    25
FIG. 4    Global Erythropoietin Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026)    26
FIG. 5    Global Growth Hormone Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026)    27
FIG. 6    Global Stem Cells Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026)    28
FIG. 7    Global Other Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026)    29
FIG. 8    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Market Share (%) by Applications in 2018    31
FIG. 9    Global Traumatic Brain Injury Therapeutics Market for Focal TBI Consumption and Growth Rate (%), (2014 – 2026)    32
FIG. 10    Global Traumatic Brain Injury Therapeutics Market for Open TBI Consumption and Growth Rate (%), (2014 to 2026)    33
FIG. 11    Global Traumatic Brain Injury Therapeutics Market for Closed TBI Consumption and Growth Rate (%), (2014 – 2026)    34
FIG. 12    Global Traumatic Brain Injury Therapeutics Market for Diffuse TBI Consumption and Growth Rate (%), (2014 – 2026)    35
FIG. 13    Global Traumatic Brain Injury Therapeutics Market Size Comparison and Growth Rate (%) by Regions (2014-2026)    36
FIG. 14    North America Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    38
FIG. 15    Europe Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    39
FIG. 16    China Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    40
FIG. 17    Japan Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    41
FIG. 18    Southeast Asia Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    42
FIG. 19    India Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    43
FIG. 20    South America Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    44
FIG. 21    Middle East & Africa Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2014-2026)    45
FIG. 22    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Status and Outlook (2014-2026)    46
FIG. 23    2018 Global Traumatic Brain Injury Therapeutics Revenue Share by Manufacturers    49
FIG. 24    Banyan Biomarkers, Inc. Revenue Market Share (%) (2014-2018)    53
FIG. 25    ElMindA Ltd. Revenue Market Share (%) (2014-2018)    59
FIG. 26    Grace laboratories, LLC. Revenue Market Share (%) (2014-2018)    64
FIG. 27    NeuroVive Pharmaceutical AB Revenue Market Share (%) (2014-2018)    69
FIG. 28    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Regions (2014-2019)    87
FIG. 29    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Regions, 2018    88
FIG. 30    Revenue Share of Traumatic Brain Injury Therapeutics by Types (2014-2019)    90
FIG. 31    2018 Revenue Market Share (%) of Traumatic Brain Injury Therapeutics by Types    91
FIG. 32    Global Traumatic Brain Injury Therapeutics Consumption Market Share (%) by Applications (2014-2019)    94
FIG. 33    Global Traumatic Brain Injury Therapeutics Consumption Market Share (%) by Applications in 2018    95
FIG. 34    North America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2014-2019)    97
FIG. 35    North America Traumatic Brain Injury Therapeutics Market Size by Type 2018    98
FIG. 36    North America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    99
FIG. 37    North America Traumatic Brain Injury Therapeutics Market Size by Application 2018    100
FIG. 38    Europe Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2014-2019)    101
FIG. 39    Europe Traumatic Brain Injury Therapeutics Market Size by Type 2018    102
FIG. 40    Europe Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    103
FIG. 41    Europe Traumatic Brain Injury Therapeutics Market Size by Application 2018    104
FIG. 42    China Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2014-2019)    105
FIG. 43    China Traumatic Brain Injury Therapeutics Market Size by Type 2018    106
FIG. 44    China Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    107
FIG. 45    China  Traumatic Brain Injury Therapeutics Market Size by Application 2018    108
FIG. 46    Japan Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Types (2014-2019)    109
FIG. 47    Japan Traumatic Brain Injury Therapeutics Market Size by Type 2018    111
FIG. 48    Japan Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    112
FIG. 49    Japan Traumatic Brain Injury Therapeutics Market Size by Application 2018    114
FIG. 50    Southeast Asia Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2014-2019)    115
FIG. 51    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type 2018    117
FIG. 52    Southeast Asia Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    118
FIG. 53    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application 2018    119
FIG. 54    India Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    120
FIG. 55    India Traumatic Brain Injury Therapeutics Market Size by Type 2018    122
FIG. 56    India Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    123
FIG. 57    India Traumatic Brain Injury Therapeutics Market Size by Application 2018    124
FIG. 58    South America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2014-2019)    125
FIG. 59    South America Traumatic Brain Injury Therapeutics Market Size by Type 2018    126
FIG. 60    South America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    127
FIG. 61    South America Traumatic Brain Injury Therapeutics Market Size by Application 2018    128
FIG. 62    Middle East & Africa Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2014-2019)    129
FIG. 63    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Type 2018    130
FIG. 64    Middle East & Africa Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2014-2019)    131
FIG. 65    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Application 2018    133
FIG. 66    Manufacturing Cost Structure of Traumatic Brain Injury Therapeutics    134
FIG. 67    USA Labor Cost Analysis    135
FIG. 68    Cost of Employing a Factory Worker    136
FIG. 69    2017 Estimated Labor Costs for the Whole Economy in EUR    137
FIG. 70    Monthly Minimum Wages in Asia 2016    138
FIG. 71    China Labor Costs    139
FIG. 72    Traumatic Brain Injury Therapeutics Marketing Channels Status    141
FIG. 73    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    145
FIG. 74    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) Forecast by Regions (2019-2026)    147
FIG. 75    North America Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    148
FIG. 76    Europe Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    149
FIG. 77    China Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    150
FIG. 78    Japan Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    151
FIG. 79    Southeast Asia Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    152
FIG. 80    India Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    153
FIG. 81    South America Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    154
FIG. 82    Middle East & Africa Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026)    155
FIG. 83    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) Forecast by Type (2019-2026)    157
FIG. 84    Global Traumatic Brain Injury Therapeutics Consumption Forecast by Application (2019-2026)    159
FIG. 85    North America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    160
FIG. 86    North America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    162
FIG. 87    Europe Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    164
FIG. 88    Europe Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    166
FIG. 89    China Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    168
FIG. 90    China Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    170
FIG. 91    Japan Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    172
FIG. 92    Japan Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    174
FIG. 93    Southeast Asia Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    176
FIG. 94    Southeast Asia Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    178
FIG. 95    India Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    180
FIG. 96    India Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    182
FIG. 97    South America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    184
FIG. 98    South America Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    186
FIG. 99    Middle East & Africa Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Type (2019-2026)    188
FIG. 100    Middle East & Africa Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Application (2019-2026)    190

List of Tables

TABLE 1    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (%) Comparison by Types (2014-2019)    23
TABLE 2    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Comparison by Applications (2014-2026)    30
TABLE 3    Traumatic Brain Injury Therapeutics Market Revenue (USD Million) Comparison by Regions (2014-2026)    37
TABLE 4    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Manufacturers (2014-2018)    47
TABLE 5    Global Traumatic Brain Injury Therapeutics Revenue Share by Manufacturers (2014-2018)    48
TABLE 6    Global Traumatic Brain Injury Therapeutics Revenue Share by Manufacturers (2014-2018)    49
TABLE 7    Banyan Biomarkers, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors    50
TABLE 8    Banyan Biomarkers, Inc. Revenue (USD Million), Gross Margin (%) and Market Share (%) (2014-2018)    52
TABLE 9    ElMindA Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors    56
TABLE 10    ElMindA Ltd. Revenue (USD Million), Gross Margin (%) and Market Share (%) (2014-2018)    58
TABLE 11    Grace laboratories, LLC. Basic Information, Manufacturing Base, Sales Area and Its Competitors    61
TABLE 12    Grace laboratories, LLC. Revenue (USD Million), Gross Margin (%) and Market Share (%) (2014-2018)    63
TABLE 13    NeuroVive Pharmaceutical AB Basic Information, Manufacturing Base, Sales Area and Its Competitors    66
TABLE 14    NeuroVive Pharmaceutical AB Revenue (USD Million), Gross Margin (%) and Market Share (%) (2014-2018)    68
TABLE 15    BHR Pharma, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors    71
TABLE 16    Cerora, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors    75
TABLE 17    Neuro Assessment Systems, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors    78
TABLE 18    Silver Creek Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors    82
TABLE 19    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Regions (2014-2019)    85
TABLE 20    Global Traumatic Brain Injury Therapeutics Revenue Market Share (%) by Regions (2014-2019)    86
TABLE 21    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Types (2014-2019)    89
TABLE 22    Global Traumatic Brain Injury Therapeutics Revenue Share (%) by Types (2014-2019)    89
TABLE 23    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Applications (2014-2019)    92
TABLE 24    Global Traumatic Brain Injury Therapeutics Consumption Market Share (%) by Applications (2014-2019)    93
TABLE 25    Global Traumatic Brain Injury Therapeutics Revenue Growth Rate by Applications (2014-2019)    96
TABLE 26    North America Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    98
TABLE 27    North America Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    100
TABLE 28    Europe Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    102
TABLE 29    Europe Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    104
TABLE 30    China Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    106
TABLE 31    China Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    108
TABLE 32    Japan Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    110
TABLE 33    Japan Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    113
TABLE 34    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    116
TABLE 35    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    119
TABLE 36    India Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    121
TABLE 37    India Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    124
TABLE 38    South America Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    126
TABLE 39    South America Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    128
TABLE 40    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    130
TABLE 41    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Application (2014-2019)    132
TABLE 42    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast by Regions (2019-2026)    146
TABLE 43    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast by Type (2019-2026)    156
TABLE 44    Global Traumatic Brain Injury Therapeutics Revenue (USD Million) Forecast by Application (2019-2026)    158
TABLE 45    North America Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    161
TABLE 46    North America Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    163
TABLE 47    Europe Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    165
TABLE 48    Europe Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    167
TABLE 49    China Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    169
TABLE 50    China Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    171
TABLE 51    Japan Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    173
TABLE 52    Japan Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    175
TABLE 53    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type (2014-2019)    177
TABLE 54    Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    179
TABLE 55    India Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    181
TABLE 56    India Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    183
TABLE 57    South America Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    185
TABLE 58    South America Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    187
TABLE 59    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Type (2019-2026)    189
TABLE 60    Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Application (2019-2026)    191


 
Traumatic brain injury can cause immediate and significant damage to human's skull and the tissues beneath it which can lead to long-term cognitive and psychological damages. Traumatic brain injury (TBI) can be a major cause of headache, Nausea or vomiting, fatigue or drowsiness, problems with speech, difficulty sleeping, death and disability so traumatic brain injury therapeutics is used as a therapy for prevention of secondary brain damage and reduce the symptoms of traumatic brain injury.

The research and development activities and large number of clinical trials in order to develop effective therapies led the demand for the brain trauma indicator across the globe which gives accurate diagnosis of TBI. In addition to this, the market is driven by the entries of new molecular therapies like stem cell therapy and progesterone therapy. Thus, technological advancement helps in TBI therapy which provides brain network activation technique which combines electroencephalography (method to record electrical activity of the brain) and event related potential testing procedures with advanced algorithms and machine-learning. However, delayed diagnosis and low government funding for the research of TBI hamper the market for TBI therapeutics.

In terms of revenue, global traumatic brain injury therapeutics market in 2018 stood at USD XX million and is expected to reach USD XX million by 2026 growing at a CAGR of 4.74% from 2019 to 2026.

On the basis of type, traumatic brain injury therapeutics can be segmented as Acetylcholinesterase Inhibitors, Erythropoietin, Growth Hormone, Stem Cells and Other. Growth Hormone accounted for largest share of total revenue generated because growth hormone is the most common hormone deficit and has the same symptoms as traumatic brain injury which can be observe in many patients.

Major applications of traumatic brain injury therapeutics can be classified as Focal TBI, Open TBI, Closed TBI and Diffuse TBI. The demand of traumatic brain injury therapeutics is highest from Focal TBI because this is the major injury of scalp, skull fracture and surface contusions.

Region wise, global traumatic brain injury therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America held a major share in the market because of its developed economic condition, investments in technological advancements and general awareness among the public.

Some of the global major players operating in the traumatic brain injury therapeutics market include: Banayan Biomarkers Inc., ElMindA Ltd., Grace Laboratories LLC, Neurovive Pharmaceuticals AB and Others.

The Traumatic Brain Injury Therapeutics Market is segmented as follows:

Global Traumatic Brain Injury Therapeutics Market: Product analysis
  • Acetylcholinesterase Inhibitors
  • Erythropoietin
  • Growth Hormone
  • Stem Cells
  • Others
Global Traumatic Brain Injury Therapeutics Market: Application analysis
  • Focal TBI
  • Open TBI
  • Closed TBI
  • Diffuse TBI
Global Traumatic Brain Injury Therapeutics Market: Region analysis
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy and Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Colombia and Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, UAE and South Africa Rest of Middle East)